Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Lilly-backed Orbis does up to $1.4B macrocycle deal with Novo

Orbis Medicines will help Novo create macrocycles — those ring-shaped molecules that marry the best of antibodies and small molecules — for cardiometabolic diseases as part of an up to $1.4 billion alliance. The Thursday morning pact ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at endpoints.news →

More in Health & Medicine

More from Thursday 17 September →